Jin Medical International Ltd. (ZJYL) — Institutional Holders, Q4 2025

10 institutional investment managers reported a ZJYL position on SEC Form 13F-HR for the quarter ended December 31, 2025, with a combined reported value of $88.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ZJYL in Q4 2025: what funds did

Funds that filed a 13F for both Q3 2024 and Q4 2025, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

10

Added to

0

Trimmed

0

Sold out

2

Biggest buyers

  1. CITADEL ADVISORSNew · +117,794 sh+$25.9K
  2. GEODE CAPITAL MANAGEMENTNew · +106,540 sh+$23.4K
  3. JANE STREET GROUPNew · +50,920 sh+$11.2K
  4. RENAISSANCE TECHNOLOGIESNew · +40,000 sh+$8.8K
  5. OSAICNew · +32,000 sh+$7.0K

Biggest sellers

  1. ROYAL BANK OF CANADASold out · -646 sh-$142.00
  2. BNP PARIBAS FINANCIAL MARKETSSold out · -155 sh-$34.00

ZJYL 13F holders ranked 1–10 of 10

Institutional investors reporting a position in Jin Medical International Ltd. on SEC Form 13F-HR for Q4 2025, ranked by reported value.
InstitutionValueQoQ
CITADEL ADVISORS#1 · 117,794 sh$25.9KNew
GEODE CAPITAL MANAGEMENT#2 · 106,540 sh$23.4KNew
JANE STREET GROUP#3 · 50,920 sh$11.2KNew
RENAISSANCE TECHNOLOGIES#4 · 40,000 sh$8.8KNew
OSAIC#5 · 32,000 sh$7.0KNew
XTX Topco Ltd#6 · 28,637 sh$6.3KNew
TWO SIGMA SECURITIES#7 · 21,971 sh$4.8KNew
UBS Group AG#8 · 4,486 sh$987.00New
Bell Investment Advisors#9 · 152 sh$34.00New
MORGAN STANLEY#10 · 100 sh$22.00New

Funds that sold out of ZJYL in Q4 2025 (2)

Held ZJYL at the end of Q3 2024 and filed a Q4 2025 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held ZJYL in Q3 2024 and reported no position in Q4 2025.
InstitutionValue in Q3 2024
ROYAL BANK OF CANADA646 sh$2.0K
BNP PARIBAS FINANCIAL MARKETS155 sh$417.00

Source: Form 13F-HR filings on SEC EDGAR, Q4 2025. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q3 2024 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.